BioAtla, Inc. Revenue 2021–2021
BioAtla, Inc. annual/quarterly revenue history and growth rate from 2021 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioAtla, Inc. revenue for the quarter ending September 30, 2023 was 0.
- BioAtla, Inc. revenue for the twelve months ending September 30, 2023 was 0.
- BioAtla, Inc. annual revenue for 2021 was 300000.
BioAtla, Inc. (BCAB) — Frequently Asked Questions
BioAtla, Inc. (BCAB) is a publicly traded US company. It has a market capitalization of $119M. In fiscal 2021 it reported revenue of $300,000 and net income of -$95M. Explore BCAB's stock price, financial statements, earnings history, margins and key ratios below.
What is BioAtla, Inc.'s market cap?
BioAtla, Inc. (BCAB) has a market capitalization of $119M.
What is the BCAB stock price?
BCAB trades at $3.45 (-5.48% on the day).
How much revenue does BioAtla, Inc. make?
BioAtla, Inc. reported revenue of $300,000 in fiscal 2021.
Is BCAB profitable?
In fiscal 2021, BioAtla, Inc. reported net income of -$95M.